5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with carbostyril in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, G; Imhoff, BR; Infield, DT; Khazanov, N; McCarty, NA; Senderowitz, H; Stauffer, BB | 1 |
Hwang, TC; Lin, WY; Sohma, Y | 1 |
2 other study(ies) available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and carbostyril
Article | Year |
---|---|
Potentiators exert distinct effects on human, murine, and Xenopus CFTR.
Topics: Amino Acid Sequence; Aminophenols; Animals; Cells, Cultured; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Evaluation, Preclinical; Glycine; Hydrazines; Membrane Potentials; Mice; Nitrobenzoates; Patch-Clamp Techniques; Quinolones; Sequence Deletion; Xenopus laevis | 2016 |
Synergistic Potentiation of Cystic Fibrosis Transmembrane Conductance Regulator Gating by Two Chemically Distinct Potentiators, Ivacaftor (VX-770) and 5-Nitro-2-(3-Phenylpropylamino) Benzoate.
Topics: Adenosine Triphosphate; Aminophenols; Animals; CHO Cells; Cricetinae; Cricetulus; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Synergism; Ion Channel Gating; Models, Biological; Mutation; Nitrobenzoates; Quinolones | 2016 |